Back to Browse Journals » International Journal of Women's Health » Volume 1

Mandatory fortification with folic acid in the United States appears to have adverse effects on histone methylation in women with pre-cancer but not in women free of pre-cancer

Authors Chandrika J Piyathilake, Maurizio Macaluso, Jorge E Celedonio, et al

Published 21 September 2009 Volume 2009:1 Pages 131—137


Review by Single-blind

Peer reviewer comments 3

Chandrika J Piyathilake1, Maurizio Macaluso2, Jorge E Celedonio1, Suguna Badiga1, Walter C Bell3, William E Grizzle3

1Department of Nutrition Sciences, 2School of Public Health, 3Department of Pathology of The University of Alabama at Birmingham, AL, USA

Objective: To evaluate whether mandatory fortification of grain products with folic acid in the US is associated with changes in histone methylation in cells involved in cervical carcinogenesis.

Methods: Cervical specimens obtained before (1990 to 1992) and after mandatory folic acid fortification (2000 to 2002) were used to examine the degree of histone methylation (H3 Lys-9) by immunohistochemistry. 91 women (51 before and 40 after fortification) were diagnosed with cervical intraepithelial neoplasia (CIN) grade 3 or carcinoma in situ (CIS) and sections utilized in the study also contained normal, reactive or metaplastic cervical epithelium, CIN 1 or CIN 2. 64 women (34 before and 30 after fortification) were free of CIN and these sections contained only normal or reactive cervical epithelium. Immunohistochemical staining for H3 Lys-9, its assessment in different cell or lesion types and data entry were blinded for fortification status. For each cell type or lesion category we used PROC MIXED in SAS with the specimen identifier as a random effect and the robust variance estimator to estimate age- and race-adjusted intensity score for H3 Lys-9 in the pre- and post-fortification periods.

Results: Degree of H3 Lys-9 methylation was significantly higher (P < 0.0001) in ≥CIN 2 lesions (CIN 2, CIN 3 and CIS) than in ≤CIN 1 lesions (CIN 1, normal, reactive and metaplastic), in both pre- and post-fortification CIN 3/CIS specimens. Age- and race-adjusted mean H3 Lys-9 score was significantly higher in all cell or lesion types in CIN 3/CIS specimens obtained in the post-fortification period compared to pre-fortification period (P < 0.05, all comparisons). In contrast, in specimens obtained from women free of CIN, Lys-9 methylation in normal/reactive cervical epithelium was significantly lower in post-fortification specimens than in pre-fortification specimens (P = 0.03).

Conclusions: Higher levels of Lys-9 methylation in ≥CIN 2 compared to ≤CIN 1 lesions suggest that higher Lys-9 methylation is associated with progression of lower grade CIN to higher grade CIN. Higher Lys-9 methylation in cervical tissues of women diagnosed with CIN 3 in the postfortification period than in pre-fortification period suggest that fortification may adversely affect histone methylation in already initiated cells. Lower Lys-9 methylation in normal/reactive cervical cells of women free of CIN in the post-fortification period than pre-fortification on the other hand suggests that fortification is likely to protect against initiation of carcinogenic process in the cervix. These results suggest that mandatory fortification with folic acid in the US seems to have different effects on cancer depending on the stage of carcinogenesis. Because this is the first study to report folic acid fortification-associated differences in histone methylation and because of the limitations inherent to the approach we have taken to demonstrate these differences, validation of the results in other study populations or with other techniques for assessing histone methylation is necessary.

Keywords: folic acid, fortification, histone methylation, cervix

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other articles by this author:

A comparison of folate status in women of child-bearing age in Korea and in the United States

Hyun T, Badiga S, Jang HB, Han YH, Piyathilake CJ

Nutrition and Dietary Supplements 2012, 4:47-53

Published Date: 12 July 2012

Usefulness of serum mass spectrometry to identify women diagnosed with higher grades of cervical intraepithelial neoplasia may differ by race

Matthews R, Azuero A, Asmellash S, Brewster E, Partridge EE, Piyathilake CJ

International Journal of Women's Health 2011, 3:185-192

Published Date: 12 July 2011

Readers of this article also read:

20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway

Zhang F, Li M, Wu X, Hu Y, Cao Y, Wang X, Xiang S, Li H, Jiang L, Tan Z, Lu W, Weng H, Shu Y, Gong W, Wang X, Zhang Y, Shi W, Dong P, Gu J, Liu Y

Drug Design, Development and Therapy 2015, 9:3969-3987

Published Date: 10 August 2015

ER-α36: a novel biomarker and potential therapeutic target in breast cancer

Su XY, Xu X, Li GL, Lin BY, Cao J, Teng LS

OncoTargets and Therapy 2014, 7:1525-1533

Published Date: 30 August 2014

The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia

Shao IH, Hou CP, Chen SM, Chen CL, Lin YH, Chang PL, Tsui KH

Clinical Interventions in Aging 2013, 8:431-432

Published Date: 16 April 2013

Interest of corrective makeup in the management of patients in dermatology

Seité S, Deshayes P, Dréno B, Misery L, Reygagne P, Saiag P, Stengel F, Roguedas-Contios AM, Rougier A

Clinical, Cosmetic and Investigational Dermatology 2012, 5:123-128

Published Date: 7 September 2012

Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal

Lemoine P, Garfinkel D, Laudon M, Nir T, Zisapel N

Therapeutics and Clinical Risk Management 2011, 7:301-311

Published Date: 26 July 2011

Erratum - Intracellular heavy metal nanoparticle storage

Iannitti T, Capone S, Gatti A, et al

International Journal of Nanomedicine 2011, 6:239-240

Published Date: 26 January 2011

Near infrared planar tumor imaging and quantification using nanosized Alexa 750-labeled phospholipid micelles

Aristarchos Papagiannaros, Amit Kale, Tatyana S Levchenko, Dmitry Mongayt, et al.

International Journal of Nanomedicine 2009, 4:123-131

Published Date: 19 May 2009

Progress in analgesia for labor: focus on neuraxial blocks

J Sudharma Ranasinghe, David J Birnbach

International Journal of Women's Health 2009, 1:31-43

Published Date: 18 May 2009